z-logo
open-access-imgOpen Access
Drugs, Biogenic Amine Targets and the Developing Brain
Author(s) -
Aliya Frederick,
Gregg D. Stanwood
Publication year - 2009
Publication title -
developmental neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.893
H-Index - 82
eISSN - 1421-9859
pISSN - 0378-5866
DOI - 10.1159/000207490
Subject(s) - neuroscience , dopamine , norepinephrine , brain function , biogenic amine , acetylcholine , glutamate receptor , neurotransmitter , serotonin , drugs of abuse , human brain , psychopathology , brain development , psychology , biology , central nervous system , pharmacology , psychiatry , addiction , biochemistry , receptor
Defects in the development of the brain have a profound impact on mature brain functions and underlying psychopathology. Classical neurotransmitters and neuromodulators, such as dopamine, serotonin, norepinephrine, acetylcholine, glutamate and GABA, have pleiotropic effects during brain development. In other words, these molecules produce multiple diverse effects to serve as regulators of distinct cellular functions at different times in neurodevelopment. These systems are impacted upon by abuse of a variety of illicit drugs, neurotherapeutics and environmental contaminants. In this review, we describe the impact of drugs and chemicals on brain formation and function in animal models and in human populations, highlighting sensitive periods and effects that may not emerge until later in life.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom